학술논문

Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod® 5 Automated Insulin Delivery System
Document Type
Article
Source
In: Diabetes Technology and Therapeutics. (Diabetes Technology and Therapeutics, 30 May 2024, 26(6):383-393)
Subject
Language
English
ISSN
15578593
15209156